Daniel P. O'Day
2021
In 2021, Daniel P. O'Day earned a total compensation of $19.2M as Chairman and Chief Executive Officer at Gilead Sciences, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,446,190 |
|---|---|
| Option Awards | $3,375,004 |
| Salary | $1,650,000 |
| Stock Awards | $9,764,060 |
| Other | $994,212 |
| Total | $19,229,466 |
O'Day received $9.8M in stock awards, accounting for 51% of the total pay in 2021.
O'Day also received $3.4M in non-equity incentive plan, $3.4M in option awards, $1.7M in salary and $994.2K in other compensation.
Rankings
In 2021, Daniel P. O'Day's compensation ranked 351st out of 12,415 executives tracked by ExecPay. In other words, O'Day earned more than 97.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 351 out of 12,415 | 97th |
Division Manufacturing | 105 out of 5,505 | 98th |
Major group Chemicals And Allied Products | 33 out of 2,375 | 99th |
Industry group Drugs | 29 out of 2,096 | 99th |
Industry Biological Products, Except Diagnostic Substances | 13 out of 449 | 97th |
Pay ratio
| Daniel P. O'Day's Pay | $19,229,466 |
|---|---|
| Median Employee's Pay | $211,687 |
| Pay Ratio | 91to 1 |
In 2021, the annual total compensation of Daniel P. O'Day was $19,229,466.
The annual total compensation of the median employee at Gilead Sciences was $211,687.
The ratio of Daniel P. O'Day's pay to the pay of median employee was therefore 91 to one.
Source: SEC filing on March 24, 2022.
O'Day's colleagues
We found four more compensation records of executives who worked with Daniel P. O'Day at Gilead Sciences in 2021.